Sandbox:Hannan

Revision as of 13:05, 7 February 2019 by Hannan Javed (talk | contribs)
Jump to navigation Jump to search
Cortex Product Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others
Adenoma Aldosterone[1][2][3][4]
Cortisol[1][5][6][7]
  • N/A
Androgens[4][8][9][10]
  • Hirsutism
  • Virilization
  • Amenorrhea
  • Precocious puberty
  • Testicular atrophy & diminished libido (male)
  • Clitorimegaly
  • Male pattern baldness
  • Resistant hypertension
  • Gynecomastia
  • ↑ Serum testosterone
  • ↑ Serum androstenedione
  • ↑ Serum dehydroepiandrosterone sulfate (DHEA-S)
  • ↑ urine 17-ketosteroids
  • ↑ plasma and urine estrogens
  • Pale tan to brown
  • Pseudocapsule or the fibrous capsule
  • Nesting, alveolar, cords, trabeculae
  • Eosinophilic cytoplasm
  • May see clear, vacuolated cytoplasm
  • Well-defined
  • Solid mass
  • Homogeneous enhancement (CT contrast)
  • Hyperintense on in-phase and hypointense on oppose-phase (MRI)
  • FSH, LH, prolactin levels
  • Cortisol levels
  • FDG PET/CT
  • Pelvic Ultrasound
  • Adrenal Venous sampling
  • N/A
  • Extremely rare
  • Most androgen secreting adenomas are mixed tumors
Non-functional[1][11][12][13]
  • Asymptomatic
  • Abdominal pain
  • Abdominal distenstion
  • Nausea/vomiting
  • Sub-clinical Cushing syndrome
  • Sub-clinical hyperaldosteroism
  • Asymptomatic
  • Abdominal asymmetry
  • Abdominal mass
  • Sub-clinical Cushing syndrome
  • Sub-clinical hyperaldosteroism
  • N/L
  • ↓ Adrenal hormones
  • ↑ Serum cortisol (sub-clinical)
  • ↑ Serum aldosterone (sub-clinical)
  • ↑ Serum androgens (sub-clinical)
  • Well-defined margins
  • Large monomorphic cells
  • Abundant/foamy cytoplasm
  • Typically resemble normal adrenal histology
  • May see hemorrhage & necrosis
  • Solid, well defined mass (ultrasound)
  • High lipid content and adjacent compression (CT)
  • Hyperintense on in-phase and hypointense on oppose-phase (MRI)
  • Adrenal hormone levels
  • Blood glucose level
  • Plasma catecholamines and urinary metanephrines
  • ARR
  • Immunohistochemical staining
  • N/A
  • 2-fold increased risk for Diabetes mellitus in some studies
  • Work up must exclude Cushing syndrome, pheochromocytoma and adrenal carcinoma
Carcinoma[12][14][15][16][17]
  • Cortisol
  • Aldosterone
  • Androgens
  • Non-functional
  • Erythropoietin
  • Symptoms of adrenal hormones as mentioned in adrenal adenomas
  • Constitutional symptoms such as cachexia, night sweats, fever
  • Localized symptoms such as abdominal pain, mass, fullness, early satiety
  • Hypertension
  • Signs of adrenal hormones as mentioned in adrenal adenomas
  • Constitutional
  • Localized signs such as abdominal mass,abdominal distension
  • N/L
  • ↑ Serum cortisol
  • ↑ Serum aldosterone
  • ↑ Serum androgens
  • Hypokalemia
  • Alkalosis
  • ↑ ARR
  • ↑ Blood glucose
  • brown to orange to yellow
  • Necrosis & mitosis
  • Hypercellular & solid and/or diffuse growth pattern
  • Low to high lipid content
  • Nuclear pleomorphism
  • Lymphovascular invasion
  • Heterogeneous enhancement (CT)
  • Heterogenous hyper-intensity (T2-weighted) and hypo-intensity on (T1-weighted) (MRI)
  • Heterogeneous mass with intense FDG uptake greater than liver ([18F]FDG PET/CT)
  • Serum ACTH
  • Low dose and high dose dexamethasone suppression test
  • Urinary adrenal metabolites
  • Proton MR spectroscopy
  • [11C]MTO PET
  • Immunohistochemical staining
  • N/A
  • May cause hypoglycemia (Anderson's syndrome}
  • May be associated with:
    • hyperreninemic
    • hyperaldosteronism
    • erythropoietin-associated polycythemia
    • leukocytosis
Hyperplasia[2][5][4][8][9][15][18][19]
  • Cortisol (most common)
  • Aldosterone
  • Androgens
  • Non-functional
  • Depending on the product secreted, may present as:
    • Cushing syndrome
    • Hyperaldosteronism
    • Virilization, hirsutism, menstrual irregularities, testicular atrophy & diminished libido
  • Localized symptoms such as abdominal pain, mass, fullness, early satiety
  • Depending on the product secreted, may present as:
    • Cushing syndrome
    • Hyperaldosteronism
    • Virilization, hirsutism, menstrual irregularities, gynaecomastia and testicular atrophy
  • Localized signs such as abdominal mass,abdominal distension
  • ↑ Serum cortisol
  • ↑ Serum aldosterone
  • ↑ Serum androgens
  • Hypokalemia
  • Alkalosis
  • ↑ ARR
  • ↑ Blood glucose
  • ↑ Serum testosterone
  • ↑ Serum androstenedione
  • ↑ Serum dehydroepiandrosterone sulfate (DHEA-S)
  • ↑ plasma and urine estrogens
  • Diffuse or nodular enlargement
  • Increased thickness of zona reticularis and fasciculata
  • Large polygonal cells with/without lipid depletion
  • May contain pigment (lipofuscin)
  • endocrine atypia
  • Small micronodules
  • Adrenal mass
  • Unilateral or bilateral adrenal enlargement or thickening
  • Density and signaling is same as that of normal adrenal gland
  • Adrenal venous sampling
  • Pelvic & pituitary imaging
  • Genetic testing
  • Fludrocortisone Suppression Testing
  • Saline Infusion Testing
  • Diurnal plasma cortisol variation
  • Low dose and high dose dexamethasone suppression test
  • FSH, LH, prolactin levels
  • Cortisol levels
  • N/A
  • Congenital adrenal hyperplasia presents in children/young adults
  • Associated with Carney complex
  • Plasma levels of cortisol and ACTH may show false positive and false negative results due to normal diurnal hormonal variation
Medulla Product Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others
Pheochromocytoma[20][21][22][23][24]
Neuroblastoma[15][25][26][27]
  • Constitutional
  • Failure to thrive
  • Abdominal pain
  • Diarrhea
  • Constipation
  • Dyspnea
  • Prolonged cough
  • Strabismus
  • Proptosis
  • Abdominal mass
  • Pallor
  • Tachycardia
  • Hypertension
  • Failure to thrive
  • Strabismus
  • Proptosis
  • N/L
  • Slight elevation in catecholamines
  • ↑ Urinary metanephrines
  • ↓ Hb
  • ↑ Ferritin
  • ↑ LDH
  • Thrombocytosis
  • Cells may show:
    • Undifferentiation
    • Poor differentiation
    • Differentiating neuroblasts
  • Necrosis
  • Salt and pepper chromatin
  • spindle-like fibers
  • Large mass extending across the midline (CT)
  • Heterogeneous enhancement (CT)
  • Calcification & hemorrhage (CT & MRI)
  • Non-homogeneous and hyperintense (T2-weighted)
  • Hypointense (T1-weighted)
  • Immunohistochemical staining
  • PET scan
  • Octereoscan
  • 131I-metaiodobenzylguanidine (MIBG) scintigraphy
  • FISH
  • Genetic testing
  • Pathological examinations
Stains positive for
Ganglioneuroma[15][28][29][30]
  • Asymptomatic
  • Abdominal pain
  • Diarrhea
  • N/L
  • Abdominal mass
  • Hypertension
  • N/L
  • ↑ plasma and urinary catecholamine
  • ↑ VIP
  • ↑ cortisol and testosterone
  • Mature type: mature Schwann cells, ganglion cells and perineural cells
  • Maturing type: Schwann cells, ganglion cells and perineural cells with varying maturation
  • well-defined, Homogeneous (CT)
  • Punctate or discrete calcification (CT)
  • Hypointense (T1-weighted)
  • Varied signal (T2-weighted)
  • Ultrasound
  • Immunohistochemical staining
  • 18F-2-fluoro-deoxy-D-glucose-positron emission tomography (PET)
  • Pathological examinations

Stains positive for

  • S100
  • Synaptophysin
  • Neurofilament (NF) protein
  • Chromogranin A
  • Glial fibrillary acidic protein
  • PGP 9.5
  • Type IV collagen
  • VIP
Stroma Product Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others
Lipoma/Myolipoma[15][31][32][33]
  • N/A
  • Asymptomatic
  • Abdominal pain
  • Back pain
  • Fever
  • N/L
  • Abdominal mass
  • Fever
  • N/L
  • Yellow adipose tissue
  • Hemorrhagic foci
  • Islands of hematopoietic cells (myolipoma) and mature fat cells (Lipoma)
  • Retro-peritoneal mass
  • Well-defined heterogenous enhancement
  • High signal (MRI)
  • RFTs
  • LFTs
  • Urine analysis
  • Ultrasound
  • Pathological examinations
  • Myolipoma: mature adipose tissue and haematopoietic elements
  • Lipoma: mature fat cells
Others Product Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others
Tuberculosis[34][35][36][37][38]
  • N/A
  • Weakness
  • Malaise
  • Nausea
  • Fatigue
  • Anorexia
  • Abdominal pain
  • Orthostatic hypotension
  • Constipation
  • Salt craving
  • Adrenal crisis
  • Symptoms of pulmonary TB
  • Weight loss
  • Hyperpigmentation of the skin
  • Fever
  • Hypotension
  • Adrenal crisis
  • Signs of pulmonary tuberculosis
  • Anemia
  • Leukocytosis
  • Hyponatremia
  • Hyperkalemia
  • Hypoglycemia
  • Low early morning serum cortisol levels
  • Low basal urinary cortisol
  • ↑ ACTH
  • ↓ Aldosterone
  • ↑ Plasma renin
  • Enlarged, necrotic adrenal glands
  • Central caseous necrosis
  • Rim of granulomatous inflammatory cells (Langerhans giant cells and lymphocytes)
  • Identifiable acid-fast stain-positive bacteria with Ziehl-Neelsen or fluorescent stains
  • Enlarged adrenal glands
  • Calcification
  • Hypodense areas (CT scan)
  • Rim enhancement (CT scan)
  • High FDG uptake by adrenal glands (18-FDG PET CT)
  • Laparoscopic adrenalectomy
  • Chest X-ray
  • Chest CT scan
  • Tuberculin test
  • ACTH stimulation test
  • Insulin induced hypoglycemia
  • Metyrapone stimulation tests
  • N/A
  • Majority of the cases are secondary to:
    • Pulmonary TB
    • Genitourinary TB
    • HIV infection
  • May present with shock with severe hypotension and hypoglycemia due to glucocorticoid insufficiency
Histoplasmosis[39][40][41][42][43]
  • N/A
  • No adrenal symptoms
  • Adrenal insufficiency:
    • Weakness & malaise
    • Nausea, fatigue and anorexia
    • Abdominal pain
    • Orthostatic hypotension
    • Constipation
    • Salt craving
  • Symptoms of pulmonary/skin/bone histoplasmosis
  • Weight loss
  • Hyperpigmentation of the skin
  • Fever
  • Hypotension
  • Adrenal crisis
  • Signs of pulmonary/skin/bone histoplasmosis
  • Anemia
  • Leukocytosis
  • Hyponatremia
  • Hyperkalemia
  • Hypoglycemia
  • Low early morning serum cortisol levels
  • Low basal urinary cortisol
  • ↑ ACTH
  • ↓ Aldosterone
  • ↑ Plasma renin
  • Necrotizing granulomatous inflammation similar to tuberculosis
  • Capsulated yeast forms of Histoplasma (Giemsa stain)
  • Histoplasma identification (H&E stain)
  • Focal ovoid bodies with a clear halo (PAS stain)
  • Enlarged adrenal glands
  • Calcification
  • Heterogeneous enhancement (CT)
  • Isointense adrenal mass (MRI)
  • Abnormal FDG uptake by adrenal glands (18-FDG PET CT)
  • Laparoscopic adrenalectomy
  • Endoscopic ultrasound
  • Abdominal ultrasound
  • Chest X-ray
  • ACTH stimulation test
  • Metyrapone stimulation tests
  • Ultrasound-guided fine needle aspiration cytology (USG-FNAC)
  • Patient may exhibit no clinical manifestations of adrenal involvement
  • Majority of the cases are secondary to:
    • Pulmonary histoplasmosis
    • HIV infection
  • May present with shock with severe hypotension and hypoglycemia due to glucocorticoid insufficiency
Cysts[15][44][45][46]
  • N/A
  • Abdominal pain
  • abdominal mass
  • Abdominal fullness
  • Hematuria
  • Infection
  • Symptoms of malignancy (Cystic part of other tumors)
  • Abdominal mass & assymetry
  • Fever
  • Hypertension (Renal compression)
  • Hypotension (Hemorrhage into cyst)
  • Signs of malignancy (Cystic part of other tumors)
  • N/L
  • Anemia
  • Leukocytosis
  • Vascular or endothelial cyst: lined by flattened endothelial cells
  • Epithelial: lined by epithelium
  • Pseudocyst: lined by fibrous tissue
  • Hydatid cyst: 3 layers (germinal layer, laminated membrane and dense fibrovascular tissue)
  • Homogeneous mass
  • No enhancement
  • Calcification
  • Low density (CT)
  • High signal (MRI)
  • Circumscribed anechoic or hypoechoic mass (Ultrasound)
  • Complete endocrine panel
  • [18F]FDG PET/CT (if malignancy is suspected)
  • Biopsy (if maligancy is suspected)
  • ACTH stimulation test
  • Ultrasonography
  • 3 major subtypes
    • Pure cysts (vascular or endothelial cyst, pseudocyst and 'true' epithelial cysts)
    • Parasitic cysts
    • Cystic part of an otherwise solid tumor
Haematoma[15][47][48][49]
  • N/A
  • Flank/back pain
  • Weakness
  • Hypovolemic shock
  • Adrenal crisis
  • Adrenal insufficiency (massive hemorrhage)
  • Symptoms of underlying cause
  • Hypotension
  • Abdominal/flank mass
  • Hypovolemic shock
  • Adrenal crisis
  • Adrenal insufficiency (massive hemorrhage)
  • Signs of underlying cause
  • Anemia
  • ↓ Serum and urinary adrenal hormones and metabolites
  • Findings related to underlying cause
  • Pseudocyst: lined by fibrous tissue
  • Findings related to underlying cause
  • High density (acute hemorrhage on CT)
  • Isointense and low signal (Early hemorrhage on MRI)
  • Hypointense (Late hemorrhage on MRI)
  • Adrenal ultrasound
  • ACTH stimulation test
  • Tests related to underlying cause
  • N/A
  • Majority of the cases in neonantal peiod
  • Majority of the cases caused by trauma
Hemangioma[15][50][51][52]
  • Cortisol (rare)
  • Aldosterone (rare)
  • Androgens (rare)
  • Abdominal mass & discomfort
  • Nausea & vomiting
  • Back pain
  • Hypovolemic shock (hemorrhage)
  • Symptoms of hormonal excess (very rare)
  • Abdominal mass
  • Hypovolemic shock (hemorrhage)
  • Symptoms of hormonal excess (very rare)
  • N/L
  • ↓ Hb (hemorrhage)
  • ↑ Serum and urinary adrenal hormones and metabolites (very rare)
  • Most often cavernous
  • Peripheral dilated vascular spaces
  • Monostromatic endothelium
  • Absence of atypia
  • Central necrosis
  • Calcification
  • Hemorrhage
  • Calcifications
  • Phleboliths
  • Irregular peripheral enhancement (CT)
  • Hyperintensity (T2) hypointensity (T1)(MRI)
  • Peripheral spotty and centripetal enhancement (MRI)
  • Complete endocrine panel
  • Ultrasound
  • FDG-PET scan
  • Endoscopic ultrasound
  • Post-resection biopsy (if malignancy is suspected)
  • Histopathology
  • Majority of the cases diagnosed incidentally
  • Majority of the lesions are non-functional with female pre-dominance
Lymphoma[15][53][54][55]
  • N/A
  • Fatigue
  • Loss of appetite
  • Weight loss
  • Pigmentation of skin
  • Flank/abdominal pain
  • Fever
  • Nausea & vomiting
  • Hypotension
  • Altered mental status
  • Abdominal/flank mass
  • Fever
  • Weight loss
  • ↑ ESR
  • ↑ LDH
  • ↑ Serum ACTH
  • ↓ Serum sodium
  • Low early morning serum cortisol levels
  • Low basal urinary cortisol
  • ↓ Aldosterone
  • Diffuse growth pattern with large cells ( 5× normal lymphocytes) resembling immunoblasts
  • Extensive necrosis
  • May resemble anaplastic large cell lymphoma or metastatic carcinoma
  • Abundant T-cells
  • Heterogeneous mass
  • Hemorrhages
  • Necrosis
  • Enlarged retroperitoneal lymph nodes (MRI)
  • Low intensity (T1-MRI)
  • High intensity (T2-MRI))
  • Complete endocrine panel
  • Ultrasound
  • ACTH stimulation test
  • CT-guided needle biopsy
  • 18F-fluorodeoxyglucose (FDG) positron emission tomography PET/CT
  • Histopathology
  • May stain positive for
    • CD3, CD19, CD20, CD22
    • BCL6+ / CD10+
    • CD43, CD45
    • Surface Ig
    • CD68
    • CD79a
    • LCA
    • Pax.5
Cystic Lymphangioma[15][56][57][58]
  • N/A
  • Asymptomatic
  • Flank/back/abdominal pain
  • Abdominal/flank mass
  • GI obstruction
  • N/L
  • Palpable mass
  • Hypertension
  • Fever
  • N/L
  • Cystic channels and spaces
  • Flat endothelial cells
  • Mature lymphoid aggregates
  • Well-demarcated
  • Low-density
  • Calcification
  • T1 hypointense & T2 hyperintense (MRI)
  • Complete endocrine panel
  • Ultrasound
  • FDG-PET scan
  • Aspiration & biopsy
  • Histopathology
  • Associated with Gorlin-Goltz syndrome
  • Stains positive for CD31, CD34, and D2-40 and negative for cytokeratin
Teratoma[15][59][60][61]
  • N/A
  • Asymptomatic
  • Abdominal/back discomfort & pain
  • Abdominal distension
  • Lumbago
  • Nausea, vomiting
  • Local obstructive symptoms
  • N/L
  • Abdominal distension
  • Abdominal mass
  • Weight loss
  • Urinary retention
  • Lower extremity edema
  • Peritoneal effusion or peritonitis (rupture)
  • N/L
  • Fibrous tissue, adipose tissue and muscle fibers
  • stratified squamous epithelium, hair shafts, fat cells, GI and respiratory epithelium
  • Necrosis
  • Calcification
  • Heterogeneous
  • Mixed echo (U/S)
  • Mixed density elements (CT scan)
  • Egg-shell calcification
  • Mild enhancement
  • Mixed signals (MRI)
  • Complete endocrine panel
  • 18F-fluorodeoxyglucose (FDG) positron emission tomography PET/CT
  • Post-resection biopsy (if malignancy is suspected)
  • N/A
  • Derived from germ layers
  • Majority are benign, but about one forth of adrenal teratomas are malignant lesions
Metastases[15][62][63][64][65]
  • Related to the primary tumor
  • Asymptomatic
  • Adrenal insufficiency
  • Abdominal mass & discomfort
  • Symptoms due to primary tumor that may include:
    • Lung cancer
    • Breast cancer
    • Gastric cancer
    • Liver cancer
    • Pancreatic cancer
    • Renal cell carcinomas
    • Melanoma
    • Lymphoma
  • Asymptomatic
  • Adrenal insufficiency
  • Abdominal mass
  • Signs due to primary tumor that may include
    • Lung cancer
    • Breast cancer
    • Gastric cancer
    • Liver cancer
    • Pancreatic cancer
    • Renal cell carcinomas
    • Melanoma
    • Lymphoma
  • Varies depending on the primary tumor
  • N/L
  • If adrenal insufficiency:
    • Hyponatremia
    • Hyperkalemia
    • Hypoglycemia
    • Low early morning serum cortisol levels
    • Low basal urinary cortisol
    • ↑ ACTH
    • ↓ Aldosterone
    • ↑ Plasma renin
  • Single or multiple firm masses
  • Hemorrhage
  • Necrosis
  • Morphology similar to the primary tumor
  • Compression and atrophy of adjacent adrenal tissue
  • Calcification
  • Hemorrhage
  • Irregular peripheral enhancement
  • Low signal on T1-weighed MRI and high signal on T2-weighed MRI

OR

  • Isointense on T1- and T2-weighed MRI
  • Blood and urine lab testing
  • Complete endocrine panel
  • Imaging of chest, abdomen, and pelvis
  • Immunohistochemistry
  • Endoscopy
  • MRCP & ERCP
  • 18F-fluorodeoxyglucose (FDG) positron emission tomography PET/CT
  • N/A
  • Metastases more common than primary adrenal tumors
  • Adrenal hemorrhage is the most serious complication and may present as adrenal crisis and/or shock

References

  1. 1.0 1.1 1.2 Park JJ, Park BK, Kim CK (June 2016). "Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses". Br J Radiol. 89 (1062): 20151018. doi:10.1259/bjr.20151018. PMC 5258164. PMID 26867466.
  2. 2.0 2.1 Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P (August 2015). "Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas". Mol. Cell. Endocrinol. 411: 146–54. doi:10.1016/j.mce.2015.04.022. PMC 4474471. PMID 25958045.
  3. Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (May 2010). "Laboratory investigation of primary aldosteronism". Clin Biochem Rev. 31 (2): 39–56. PMC 2874431. PMID 20498828.
  4. 4.0 4.1 4.2 Guerrisi A, Marin D, Baski M, Guerrisi P, Capozza F, Catalano C (2013). "Adrenal lesions: spectrum of imaging findings with emphasis on multi-detector computed tomography and magnetic resonance imaging". J Clin Imaging Sci. 3: 61. doi:10.4103/2156-7514.124088. PMC 3935261. PMID 24605256.
  5. 5.0 5.1 Stratakis CA (2008). "Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)". Endocr Dev. 13: 117–32. doi:10.1159/000134829. PMC 3132884. PMID 18493137.
  6. Zilbermint M, Stratakis CA (June 2015). "Protein kinase A defects and cortisol-producing adrenal tumors". Curr Opin Endocrinol Diabetes Obes. 22 (3): 157–62. doi:10.1097/MED.0000000000000149. PMC 4560837. PMID 25871963.
  7. Wei J, Li S, Liu Q, Zhu Y, Wu N, Tang Y, Li Q, Ren K, Zhang Q, Yu Y, An Z, Chen J, Li J (April 2018). "ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures". BMC Endocr Disord. 18 (1): 22. doi:10.1186/s12902-018-0250-6. PMC 5913873. PMID 29685132.
  8. 8.0 8.1 Arnold DT, Reed JB, Burt K (January 2003). "Evaluation and management of the incidental adrenal mass". Proc (Bayl Univ Med Cent). 16 (1): 7–12. PMC 1200803. PMID 16278716.
  9. 9.0 9.1 Rodríguez-Gutiérrez R, Bautista-Medina MA, Teniente-Sanchez AE, Zapata-Rivera MA, Montes-Villarreal J (2013). "Pure androgen-secreting adrenal adenoma associated with resistant hypertension". Case Rep Endocrinol. 2013: 356086. doi:10.1155/2013/356086. PMC 3681270. PMID 23819074.
  10. Zhou WB, Chen N, Li CJ (January 2019). "A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman". BMC Endocr Disord. 19 (1): 14. doi:10.1186/s12902-019-0342-y. PMC 6343319. PMID 30674304.
  11. Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A (October 2016). ""Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study". Ann. Intern. Med. 165 (8): 533–542. doi:10.7326/M16-0547. PMC 5453639. PMID 27479926.
  12. 12.0 12.1 Nieman LK (September 2010). "Approach to the patient with an adrenal incidentaloma". J. Clin. Endocrinol. Metab. 95 (9): 4106–13. doi:10.1210/jc.2010-0457. PMC 2936073. PMID 20823463.
  13. Li B, Guo Q, Yang H, Guan J (January 2013). "Giant non-functional adrenal adenoma: A case report". Oncol Lett. 5 (1): 378–380. doi:10.3892/ol.2012.978. PMC 3525484. PMID 23255953.
  14. Libé R (2015). "Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment". Front Cell Dev Biol. 3: 45. doi:10.3389/fcell.2015.00045. PMC 4490795. PMID 26191527.
  15. 15.00 15.01 15.02 15.03 15.04 15.05 15.06 15.07 15.08 15.09 15.10 15.11 Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, Liu H, Zhang T (September 2018). "CT and MRI of adrenal gland pathologies". Quant Imaging Med Surg. 8 (8): 853–875. doi:10.21037/qims.2018.09.13. PMC 6177362. PMID 30306064.
  16. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (April 2014). "Adrenocortical carcinoma". Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.
  17. Wang C, Sun Y, Wu H, Zhao D, Chen J (March 2014). "Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers". Histopathology. 64 (4): 567–76. doi:10.1111/his.12283. PMC 4282325. PMID 24102952.
  18. Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM (November 2017). "Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics". Br J Radiol. 90 (1079): 20170330. doi:10.1259/bjr.20170330. PMC 5963387. PMID 28707538. Vancouver style error: name (help)
  19. Zhang Y, Li H (2015). "Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease". Int J Clin Exp Med. 8 (10): 19311–7. PMC 4694469. PMID 26770569.
  20. Martucci VL, Pacak K (2014). "Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment". Curr Probl Cancer. 38 (1): 7–41. doi:10.1016/j.currproblcancer.2014.01.001. PMC 3992879. PMID 24636754.
  21. Kantorovich V, Pacak K (2010). "Pheochromocytoma and paraganglioma". Prog. Brain Res. 182: 343–73. doi:10.1016/S0079-6123(10)82015-1. PMC 4714594. PMID 20541673.
  22. Miller AD, Masek-Hammerman K, Dalecki K, Mansfield KG, Westmoreland SV (November 2009). "Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus)". Vet. Pathol. 46 (6): 1221–9. doi:10.1354/vp.09-VP-0022-M-FL. PMID 19605896.
  23. Kantorovich V, Eisenhofer G, Pacak K (December 2008). "Pheochromocytoma: an endocrine stress mimicking disorder". Ann. N. Y. Acad. Sci. 1148: 462–8. doi:10.1196/annals.1410.081. PMC 2693284. PMID 19120142.
  24. Eisenhofer G, Peitzsch M (December 2014). "Laboratory evaluation of pheochromocytoma and paraganglioma". Clin. Chem. 60 (12): 1486–99. doi:10.1373/clinchem.2014.224832. PMID 25332315.
  25. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG (October 2014). "Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project". J. Clin. Oncol. 32 (28): 3169–76. doi:10.1200/JCO.2014.56.1621. PMC 4171360. PMID 25154816.
  26. Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S (2014). "Epidemiological and clinical characteristics of neuroblastoma in southern iran". Iran J Ped Hematol Oncol. 4 (3): 89–96. PMC 4173027. PMID 25254086.
  27. Skoura E, Oikonomopoulos G, Vasileiou S, Kyprianou D, Koumakis G, Datseris IE (2014). "(18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma". Hell J Nucl Med. 17 (1): 58–61. doi:10.1967/s002449910116. PMID 24563879.
  28. Mylonas KS, Schizas D, Economopoulos KP (October 2017). "Adrenal ganglioneuroma: What you need to know". World J Clin Cases. 5 (10): 373–377. doi:10.12998/wjcc.v5.i10.373. PMC 5648998. PMID 29085827.
  29. Adas M, Koc B, Adas G, Ozulker F, Aydin T (April 2014). "Ganglioneuroma presenting as an adrenal incidentaloma: a case report". J Med Case Rep. 8: 131. doi:10.1186/1752-1947-8-131. PMC 4031973. PMID 24779851.
  30. Li J, Yang CH, Li LM (April 2013). "Diagnosis and treatment of 29 cases of adrenal ganglioneuroma". Eur Rev Med Pharmacol Sci. 17 (8): 1110–3. PMID 23661526.
  31. Lam KY, Lo CY (September 2001). "Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution". J. Clin. Pathol. 54 (9): 707–12. PMC 1731508. PMID 11533079.
  32. Gershuni VM, Bittner JG, Moley JF, Brunt LM (January 2014). "Adrenal myelolipoma: operative indications and outcomes". J Laparoendosc Adv Surg Tech A. 24 (1): 8–12. doi:10.1089/lap.2013.0411. PMC 3931430. PMID 24328509.
  33. Luo J, Chen L, Wen Q, Xu L, Chu S, Wang W, Alnemah MM, Fan S (2015). "Lipoadenoma of the adrenal gland: report of a rare entity and review of literature". Int J Clin Exp Pathol. 8 (8): 9693–7. PMC 4583971. PMID 26464739.
  34. Rodríguez-Gutiérrez R, Rendon A, Barrera-Sánchez M, Carlos-Reyna KE, Álvarez-Villalobos NA, González-Saldivar G, González-González JG (2016). "Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test". Int J Endocrinol. 2016: 9051865. doi:10.1155/2016/9051865. PMC 4781954. PMID 27006656.
  35. Haddara WM, van Uum SH (September 2004). "TB and adrenal insufficiency". CMAJ. 171 (7): 710, author reply 710–1. doi:10.1503/cmaj.1041046. PMC 517840. PMID 15451821.
  36. Huang YC, Tang YL, Zhang XM, Zeng NL, Li R, Chen TW (October 2015). "Evaluation of primary adrenal insufficiency secondary to tuberculous adrenalitis with computed tomography and magnetic resonance imaging: Current status". World J Radiol. 7 (10): 336–42. doi:10.4329/wjr.v7.i10.336. PMC 4620114. PMID 26516430.
  37. Vinnard C, Blumberg EA (January 2017). "Endocrine and Metabolic Aspects of Tuberculosis". Microbiol Spectr. 5 (1). doi:10.1128/microbiolspec.TNMI7-0035-2016. PMID 28233510.
  38. Rajasekharan C, Ajithkumar S, Anto V, Parvathy R (May 2013). "Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-008011. PMID 23687365.
  39. Rog CJ, Rosen DG, Gannon FH (December 2016). "Bilateral adrenal histoplasmosis in an immunocompetent man from Texas". Med Mycol Case Rep. 14: 4–7. doi:10.1016/j.mmcr.2016.11.006. PMC 5154969. PMID 27995051.
  40. Wahab NA, Mohd R, Zainudin S, Kamaruddin NA (2013). "Adrenal involvement in histoplasmosis". EXCLI J. 12: 1–4. PMC 4817423. PMID 27047312.
  41. May D, Khaled D, Gills J (July 2018). "Unilateral adrenal histoplasmosis". Urol Case Rep. 19: 54–56. doi:10.1016/j.eucr.2018.03.010. PMC 5991316. PMID 29888193.
  42. Gupta RK, Majumdar K, Srivastava S, Varakanahalli S, Saran RK (2018). "Endoscopic Ultrasound-guided Cytodiagnosis of Adrenal Histoplasmosis with Reversible CD4 T-Lymphocytopenia and Jejunal Lymphangiectasia". J Cytol. 35 (2): 110–113. doi:10.4103/JOC.JOC_234_15. PMC 5885598. PMID 29643659.
  43. Padma S, Sreehar S (May 2014). "18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient". Indian J. Med. Res. 139 (5): 786–7. PMC 4140048. PMID 25027093.
  44. Carsote M, Ghemigian A, Terzea D, Gheorghisan-Galateanu AA, Valea A (2017). "Cystic adrenal lesions: focus on pediatric population (a review)". Clujul Med. 90 (1): 5–12. doi:10.15386/cjmed-677. PMID 28246490.
  45. Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, Kasperlik-Załuska AA (December 2015). "Standards of ultrasound imaging of the adrenal glands". J Ultrason. 15 (63): 377–87. doi:10.15557/JoU.2015.0035. PMC 4710689. PMID 26807295.
  46. Olaoye IO, Adesina MD, Afolayan EA (June 2018). "A giant adrenal cyst with an uncertain preoperative diagnosis causing a dilemma in management". Clin Case Rep. 6 (6): 1074–1076. doi:10.1002/ccr3.1519. PMC 5986023. PMID 29881567.
  47. Hamilton D, Harris MD, Foweraker J, Gresham GA (February 2004). "Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection". J. Clin. Pathol. 57 (2): 208–9. PMC 1770213. PMID 14747454.
  48. Di Serafino M, Severino R, Coppola V, Gioioso M, Rocca R, Lisanti F, Scarano E (September 2017). "Nontraumatic adrenal hemorrhage: the adrenal stress". Radiol Case Rep. 12 (3): 483–487. doi:10.1016/j.radcr.2017.03.020. PMC 5551907. PMID 28828107.
  49. Ierardi AM, Petrillo M, Patella F, Biondetti P, Fumarola EM, Angileri SA, Pesapane F, Pinto A, Dionigi G, Carrafiello G (April 2018). "Interventional radiology of the adrenal glands: current status". Gland Surg. 7 (2): 147–165. doi:10.21037/gs.2018.01.04. PMC 5938278. PMID 29770310.
  50. Alhajri K, Alhasan I, Alzerwi N, Abudaff N (April 2011). "Adrenal haemangioma". BMJ Case Rep. 2011. doi:10.1136/bcr.12.2010.3604. PMC 3079485. PMID 22701011.
  51. Iwamoto G, Shimokihara K, Kawahara T, Takamoto D, Yao M, Teranishi JI, Otani M, Uemura H (2018). "Adrenal Hemangioma: A Case of Retroperitoneal Tumor". Case Rep Med. 2018: 8796327. doi:10.1155/2018/8796327. PMC 5836307. PMID 29560018.
  52. Tarchouli M, Boudhas A, Ratbi MB, Essarghini M, Njoumi N, Sair K, Zentar A (2015). "Giant adrenal hemangioma: Unusual cause of huge abdominal mass". Can Urol Assoc J. 9 (11–12): E834–6. doi:10.5489/cuaj.2967. PMC 4639440. PMID 26600897.
  53. Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F (September 2017). "The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency". Intern. Med. 56 (17): 2261–2269. doi:10.2169/internalmedicine.8216-16. PMC 5635296. PMID 28794358.
  54. Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM (February 2017). "Adrenal lymphoma: presentation, management and prognosis". QJM. 110 (2): 103–109. doi:10.1093/qjmed/hcw174. PMID 27795295.
  55. Karimi F (October 2017). "Primary Adrenal Lymphoma Presenting with Adrenal Failure: A Case Report and Review of the Literature". Int J Endocrinol Metab. 15 (4): e12014. doi:10.5812/ijem.12014. PMC 5750783. PMID 29344029.
  56. Michalopoulos N, Laskou S, Karayannopoulou G, Pavlidis L, Kanellos I (December 2015). "Adrenal Gland Lymphangiomas". Indian J Surg. 77 (Suppl 3): 1334–42. doi:10.1007/s12262-015-1206-y. PMC 4775622. PMID 27011561.
  57. Zhao M, Gu Q, Li C, Yu J, Qi H (2014). "Cystic lymphangioma of adrenal gland: a clinicopathological study of 3 cases and review of literature". Int J Clin Exp Pathol. 7 (8): 5051–6. PMC 4152068. PMID 25197378.
  58. Joliat GR, Melloul E, Djafarrian R, Schmidt S, Fontanella S, Yan P, Demartines N, Halkic N (February 2015). "Cystic lymphangioma of the adrenal gland: report of a case and review of the literature". World J Surg Oncol. 13: 58. doi:10.1186/s12957-015-0490-0. PMC 4335415. PMID 25889625.
  59. Ramakant P, Rana C, Singh KR, Mishra A (2018). "Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management". J Postgrad Med. 64 (2): 112–114. doi:10.4103/jpgm.JPGM_588_16. PMC 5954807. PMID 29067922.
  60. Li S, Li H, Ji Z, Yan W, Zhang Y (November 2015). "Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults". Oncol Lett. 10 (5): 2865–2870. doi:10.3892/ol.2015.3701. PMC 4665718. PMID 26722254.
  61. Zhou L, Pan X, He T, Lai Y, Li W, Hu Y, Ni L, Yang S, Chen Y, Lai Y (October 2018). "Primary adrenal teratoma: A case series and review of the literature". Mol Clin Oncol. 9 (4): 437–442. doi:10.3892/mco.2018.1687. PMC 6125700. PMID 30214733.
  62. Karanikiotis C, Tentes AA, Markakidis S, Vafiadis K (November 2004). "Large bilateral adrenal metastases in non-small cell lung cancer". World J Surg Oncol. 2: 37. doi:10.1186/1477-7819-2-37. PMC 535544. PMID 15541184.
  63. ABRAMS HL, SPIRO R, GOLDSTEIN N (January 1950). "Metastases in carcinoma; analysis of 1000 autopsied cases". Cancer. 3 (1): 74–85. PMID 15405683.
  64. Gerber E, Dinlenc C, Wagner JR (2004). "Laparoscopic adrenalectomy for isolated adrenal metastasis". JSLS. 8 (4): 314–9. PMC 3016821. PMID 15554272.
  65. Vaughan ED (September 1998). "Diagnosis and management of surgical adrenal disorders". Int. J. Urol. 5 (5): 401–17. PMID 9781426.